ERYTHROCYANOSIS

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting ERYTHROCYANOSIS:

# Drug Count
0 IMATINIB 4
1 ALLOPURINOL 1
2 APIXABAN 1
3 ATORVASTATIN CALCIUM 1
4 BIMATOPROST 1
5 BUPRENORPHINE HCL 1
6 CANDESARTAN 1
7 CLOPIDOGREL 1
8 FUROSEMIDE 1
9 LANSOPRAZOLE 1
See all common drugs associated with ERYTHROCYANOSIS

ERYTHROCYANOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUPRENORPHINE HCL 1 0.0011
1 SARGRAMOSTIM 1 0.0006
2 PENTOXIFYLLINE 1 0.0002
3 ROMIPLOSTIM 1 0.0001
4 BIMATOPROST 1 0.0000
5 NEBIVOLOL HYDROCHLORIDE 1 0.0000
6 CANDESARTAN 1 0.0000
7 THALIDOMIDE 1 0.0000
8 APIXABAN 1 0.0000
9 ROSUVASTATIN 1 0.0000
See all drugs enriched for association with ERYTHROCYANOSIS

ERYTHROCYANOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
2 Prostaglandin Analog [EPC] 1 0.0000
3 Factor Xa Inhibitor [EPC] 2 0.0000
4 Leukocyte Growth Factor [EPC] 1 0.0000
5 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
7 Loop Diuretic [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with ERYTHROCYANOSIS